Feasibility analysis of China's medical insurance coverage of assisted reproductive technology.

ABSTRACT: There are millions of patients experiencing infertility in China, but assisted reproductive technology (ART) is performed at the patient's expense and is difficult to afford. With the sharp decline in China's birth rate, there is a growing controversy over the inclusion of ART in medical insurance (MI). This study aims to explore the feasibility of ART coverage by MI for the first time. We obtained basic data such as the prevalence of infertility, the cost of ART, and the success rate in China with the method of meta-analysis and consulting the government bulletin. Then, we calculated the number of infertile couples in China and the total financial expenditure of MI covering ART. Finally, we discussed the feasibility of coverage, and analyzed the population growth and economic benefits aft

SUBMITTER: Huang R 

PROVIDER: S-EPMC10997767 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature